South Carolina health officials are breaking state law by refusing to implement medical marijuana access following federal rescheduling, according to a Republican state senator who has championed cannabis reform for years.
Sen. Tom Davis sent a warning to state health administrators this week, arguing that the Trump administration's decision to move cannabis to Schedule III should have automatically triggered provisions in South Carolina's existing statute. The law, Davis contends, requires the state to establish a medical program once federal barriers are removed.
"They're in violation of the law as it currently stands," Davis said, pointing to language in state code that he believes mandates action following any federal rescheduling decision.
The dispute centers on a lesser-known provision that Davis and other reform advocates inserted into state law during previous legislative sessions. While South Carolina has not passed comprehensive medical marijuana legislation like neighboring states, the existing statute contains contingency language tied to federal scheduling changes.
The Legal Argument
Davis has been the leading Republican voice for medical cannabis in South Carolina's legislature, sponsoring multiple bills over the past several years. His latest effort stalled in the statehouse, but he maintains that federal rescheduling makes that legislative fight moot.
The Trump administration's rescheduling move, which downgraded cannabis from Schedule I to Schedule III under the Controlled Substances Act, took effect earlier this year. Schedule III drugs are recognized as having accepted medical use and lower abuse potential than Schedule I substances.
South Carolina's Department of Health and Environmental Control has not responded publicly to Davis's allegations. The agency would need to establish regulatory frameworks for cultivation, dispensing, and patient access if Davis's interpretation holds.
South Carolina's Cannabis Landscape
South Carolina remains one of the most restrictive states in the Southeast for cannabis policy. The state allows only a narrow CBD oil program for patients with specific severe conditions like epilepsy. Neighboring North Carolina recently moved forward with medical marijuana legislation, and Georgia operates a limited oil program.
Davis has argued that South Carolina is losing out economically and medically by maintaining prohibition while surrounding states create legal markets. He has framed medical access as a states' rights issue that should appeal to conservative lawmakers.
The senator's previous bills included provisions for cultivation facilities, dispensaries, and a patient registry system. Those measures passed the Senate but died in the House, where leadership has been less receptive to cannabis reform.
What Happens Next
The legal standoff puts South Carolina officials in an unusual position. If Davis's interpretation is correct, the state could face legal challenges from patients or advocacy groups seeking to force implementation. But without clear guidance from the attorney general's office or a court ruling, health officials appear unwilling to act.
Davis indicated he may pursue additional legislative action in the next session to clarify the state's obligations. He could also seek an attorney general opinion on whether the existing statute requires action following federal rescheduling.
The situation highlights broader confusion about how federal rescheduling interacts with state laws. While rescheduling changes federal enforcement priorities and banking access, it does not automatically legalize cannabis at the state level or require states to create medical programs.
But Davis argues South Carolina's specific statutory language creates a different scenario, one where federal action triggers state obligations. Whether courts or the legislature will agree remains an open question.
This article is based on original reporting by www.marijuanamoment.net.